About Vaccine Conference 2022

We feel delighted to the participants from all over the world to attend the “4th International Vaccine R&D Congress” to be scheduled for August 24-25, 2022 in London, UK. The conference focuses on the theme "New Innovations in the field of Vaccines and Immunology". It will provide a global platform to discuss current and future developments and advances in vaccines, immunology research, infectious diseases research and next-generation vaccines. Vaccines Conferences 2022 brings together Vaccine scientists from industry, academia, and regulatory agencies along with business delegates to discuss recent developments and future trends in the field of vaccine process development and production. Vaccines R&D Congress will be a 2-day event with series of keynote lectures, oral and poster presentations, panel discussions involving luminaries in the field of Vaccines & Immunology.

Scientific Sessions

Session 01: Vaccine Research & Development
Vaccine Development put through a lengthy, rigorous process of scientific evaluation before licensed for general use but the process is time-consuming. The clinical trials in which vaccines are evaluated ensure that licensed vaccines are safe, effective, and appropriate to use. In the past years vaccine development did the unprecedented Ebola disease outbreak galvanized research and response, as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations. The Vaccine R&D conference discuss the topics related to vaccination and immunology.

Session 02: Vaccine and Types
Vaccines contain an active component i.e, an antigen which generates the protective immune response. These vaccines are of two types live or inactivated. Live, attenuated vaccines consists of ‘wild’ viruses or a bacterium that has been weakened in the lab so it can’t cause disease. Because a live, attenuated vaccine is a natural infection, these vaccines are “teachers” of the immune system. Whereas Inactivated vaccines are created by wild viruses or bacteria that have been grown in a culture medium and inactivated before being included in a vaccine. Inactivated toxins for bacterial diseases cause illness; or merely segments of the pathogen this includes both subunit and conjugate vaccines.

Session 03: Veterinary Vaccine
The major aims of Vaccine Conference on Veterinary vaccines are to enhance the health and welfare of animals. Vaccination of creatures are utilized both to keep their contracting sicknesses and to counteract transmission of illness to humans. Both creatures kept as pets and creatures raised as domesticated animals are routinely immunized to prevent infections transmitted from wild categories. In a few cases, wild populations might be inoculated. While it is the case of transmitted diseases and zoonotic diseases.These Veterinary vaccines have an impact not only on animal health but also on human health through preventing animal-to-human transmission of infectious diseases. The constant relation between human and animals researchers will be of major importance for finding new technologies. There are several vaccines are available and research going on in development of several veterinary vaccines i.e. rabies, canine distemper, canine parvovirus, irresistible canine hepatitis, adenovirus-2, leptospirosis, brocatelle, canine Parainfluenza infection, and Lyme ailment, and others.

Session 04: Vaccination during Pregnancy
Vaccinating the mother before, during and after the pregnancy does not only protect the mother, it will also protect the baby’s health. A risk to a developing fetus from vaccination of the mother during pregnancy is theoretical. No evidence exists of risk to the fetus from vaccinating pregnant women with inactivated virus or bacterial vaccines or toxoids. Pregnant mothers should not take live vaccines, such as Hepatitis B vaccine, polio vaccine, rabies and rotavirus vaccine; because there's a slight chance these will harm the unborn baby. During pregnancy tetanus/diphtheria/pertussis (Tdap) is recommended, preferably between 27 and 36 weeks gestation, to protect baby from whooping cough.

Session 05: Vaccination for Children

Vaccination given to children is called childhood Immunization. There are several vaccines for infants, newborn and small child’s up to 6 years so nowadays vaccination for babies are mandatory until unless the child has special circumstances, such as a compromised immune system or a neurological disorder all these precautionary steps are explained briefly on Vaccine Conference. In the society, we can see most of the children are facing with some immune disorders. Epidemics of many preventable diseases could return without vaccines, resulting in increased and unnecessary disability, illness and death among children. That is why it’s important that children, especially infants and young children receive recommended immunizations on time.

Session 06: Cancer Vaccine
Vaccines are stated to healthy people to help prevent infections, such as measles and chicken pox. These vaccines use weakened or killed germs like viruses or bacteria to start an immune response in the body. Most of the cancer vaccines work the same way, but they make the person’s immune system attack cancer cells. Cancer treatment vaccines are different from the vaccines that work opposed to viruses. These vaccines try to get the immune system to attack against cancer cells in the body. Some cancer therapy vaccines are made up of cancer cells and parts of cells, or pure antigens. Sometimes a patient’s own immune cells are detached and exposed to these substances in the lab to create the vaccine. Once the vaccine is ready, it is injected into the body to increase the immune response against cancer cells. Cancer vaccines cause the immune system to attack cells with one or more specific antigens.The immune system contains special cells for memory, it’s hoped that the vaccine might continue to work long after it’s given.

Session 07: HIV and AIDS Vaccine
Vaccine for AIDS does not yet exist, but efforts to develop a vaccine against HIV is going on. At present there is no restorative HIV immunizations affirmed by FDA,the virus that causes AIDS, have been underway for many years. CD4 cells are a type of lymphocyte,these plays an important part of the immune system. HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic. The “therapeutic” vaccine would not stop infection, but it may prevent or delay illness in people who do become infected, and might also reduce the risk of transmitting the virus to other people. The idea behind all HIV vaccines is to encourage the human immune system to fight HIV and all discussed in Vaccine Meeting.

Market Analysis

The global vaccine market is segmented into technology, indication, end-user and region. According to the technology, the market is divided into Recombinant and Conjugated Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and others. classified as Pneumococcal Disease, Influenza, Human Papillomavirus, Meningococcal Disease, Rotavirus, Chickenpox, Diphtheria, Whooping Cough and Tetanus (DPT), Polio, Hepatitis; Measles, mumps and rubella (MMR) and other indications Depending on the end user, the market is divided into pediatric, adult and traveler. Depending on the region, the market in North America (USA, Canada and Mexico) is analyzed. Europe (Germany, UK, France, Spain, Italy and rest of Europe), Asia Pacific (Japan, China, India, Australia and rest of Asia Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia and rest of LAMEA).

Scope of Vaccines Market:

Universities and Research institutes in Europe:

University of Oxford, UK
University of Cambridge, UK
Imperial College London, UK
ETH Zurich, Switzerland
UCL Universit y,UK
University of Edinburgh, UK
LMU Munich, Germany
King’s College London, UK
Karolinska Institute, Sweden
Technical University of Munich, Germany
Heidelberg University (Germany)
University of Manchester (UK)
Wageningen University & Research, Netherlands
Leiden University, Netherlands
Erasmus University Rotterdam, Netherlands
University of Zurich, Switzerland
Utrecht University, Netherlands
University of Tübingen, Germany
Humboldt University of Berlin, Germany
University of Sheffield, UK
University of York, UK
University of Liverpool, UK
Lancaster University, UK

Top Universities in MiddleEast:

Harvard University, US
Johns Hopkins University, Maryland
University of California, Los Angeles (UCLA), California
University of California, San Francisco (UCSF), California
London School of Hygiene and Tropical Medicine, London
University of Manchester, England
King’s College London, England
Sorbonne University, France
Ruprecht-Karls-Universität Heidelberg, Germany
University of Amsterdam, Netherlands
University of Sydney, Australia
Seoul National University, SouthKorea
American University of Beirut, Lebanon

Top Vaccine Research Universities in USA:

University of Montana, USA
Washington University in St. Louis, Missouri
Baylor College of Medicine, Texas
University of Manchester, England
University of Michigan (U-M), Michigan
National Institutes of Health (NIH), Maryland
Columbia University in the City of New York (CU), New York
University of Pennsylvania (Penn), Pennsylvania
Princeton University, New Jersey
Cornell University, New York
University of Maryland, College Park (UMCP), Maryland
The Ohio State University (OSU), Ohio
Boston University (BU), Massachusetts
Georgia Institute of Technology (Georgia Tech), Georgia

Target Audience:

Researchers & Scientists related to Vaccine R&D
Deans and Professors
Directors, CEOs, Presidents and Vice Presidents
University Faculty
Medical Schools/Colleges
Research Institutes
Associations and Societies related to Vaccine R&D
Vaccination Programme Organising Government and Non-government Organisations
Business Entrepreneurs
Medicine Manufacturing Companies
Vaccine Manufacturing Companies
Vaccine Developers and Investigators
Training Institutes
Vaccinology/Immunology Students.

YSA Content

Vaccine 2022 conferences will recognise participants who have significantly added value to the scientific community of research science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our International Conferences on Vaccine 2022 focuses mainly on Immunology, Vaccination, Infectious Disease Vaccines, Vaccines Research and Development, Virology, Covid Vaccines. The Vaccine Congress brings together a wealth of global expertise, from basic science to service delivery, in one of the most important and powerful areas of contemporary international public health. It is instructive and inspirational in equal measure.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

Acknowledgement as YRF Awardee
Promotion on the conference website, Young Researcher Awards and certificates
Link on the conference website
Recognition on Meetings International Award Page.
Chances to coordinate with partners around the world.

Criteria:

All presented abstracts will automatically be considered for the Award.
All the presentation will be evaluated in the conference venue
All the awards will be selected by the judges of the award category
The winners of the Young Scientist Award will receive award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

All submissions must be in English.
The topic must fit into scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
Abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated time frame will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Vaccine Conference 2022.

ADVERTISE WITH US

Meetings International is a global leader in producing high quality conferences and workshops in all major fields of science, technology and medicine.
Meetings International websites are being visited by doctors, engineers, young and budding researchers, entrepreneurs, eminent scientists, academicians and Nobel laureates from various sectors of medical and non-medical sciences. We can target impressions of your advertisements by conferences subject or region and report results in comprehensive detail.

4th International Vaccine Research and Development Congress encourages various companies and small-scale businesses to digitally advertise their products and services on its web platform which will help in informing and attracting new customers quickly and efficiently. The size and diversity of our advertising options provide clients with the very best customized marketing opportunities. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.If you are looking for a global exposure for your products and services, this is the right place for you. Display advertising improves the visibility of your products and services among specialists in your field. Bring your product to life and create instant brand awareness with a banner ad placement. Make your banner interactive to direct people to where you want them to go. We offer banner ads on our website which will be beneficial for life science professionals across the globe.Our subscribers and conference attendees can be your upcoming enthusiastic customers. If you are agricultural marketing or provide services related to plant genomics, here is your opportunity to advertise in the website that can connect you to leading experts and specialists worldwide.Advertisement banner should be provided by the advertising company and must be in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

In case you have any queries regarding advertising opportunities, please contact our representative: [email protected]

Young Scientist Award

Vaccine 2022 conferences will recognise participants who have significantly added value to the scientific community of research science and provide them outstanding Young Scientist Awards.The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our International Conferences on Vaccine 2022 focuses mainly on Immunology, Vaccination, Infectious Disease Vaccines, Vaccines Research and Development, Virology, Covid Vaccines. The Vaccine Congress brings together a wealth of global expertise, from basic science to service delivery, in one of the most important and powerful areas of contemporary international public health. It is instructive and inspirational in equal measure.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

Acknowledgement as YRF Awardee
Promotion on the conference website, Young Researcher Awards and certificates
Link on the conference website
Recognition on Meetings International Award Page.
Chances to coordinate with partners around the world.

Criteria:

All presented abstracts will automatically be considered for the Award.
All the presentation will be evaluated in the conference venue
All the awards will be selected by the judges of the award category
The winners of the Young Scientist Award will receive award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

All submissions must be in English.
The topic must fit into scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
Abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.

Conditions of Acceptance:

Award Announcements:

Official announcement of the recipients will occur after the completion of Vaccine Conference.

Be a part of 4^th International Vaccine R&D Congress

About Us

Date

Location

Download

Submit

Program

About Vaccine Conference 2022

Scientific Sessions

Market Analysis

YSA Content

ADVERTISE WITH US

Young Scientist Award

Recommended Conferences

2^ndInternational Conference on Virology and Immunology

4^th International Conference on Immunology

2nd Annual Summit on Infectious Diseases & Health care

Co-Located Event

Orthopaedics 2022

Be a part of 4th International Vaccine R&D Congress